A comparative study of real-world data before and after the establishment of one-stop intravitreal injection center in Northwest China
Author:
Corresponding Author:

Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    AIM: To compare the changes in treatment duration, treatment frequency and physician continuity in patients before and after the establishment of the anti-vascular endothelial growth factor(VEGF)intravitreal injection center(hereafter the intravitreal injection center), and to systematically assess the clinical effectiveness of this management model for chronic fundus diseases.

    METHODS: This was a retrospective study.The study included patients with fundus diseases who initially received anti-VEGF therapy at Xi'an People's Hospital between January 1, 2023, and December 31, 2024. Patients receiving treatment before the establishment of the intravitreal injection center in 2023 were assigned to the control group, while those treated after the center's establishment in 2024 were assigned to the observation group. The study compared the overall average number of injections and system retention time between the observation group and the control group. For common chronic ocular diseases, the mean number of injections, frequency of physician turnover, and proportion of patients completing the 3-injection loading phase were compared between the observation and control groups.

    RESULTS: A total of 13 792 patients(13 792 eyes)were enrolled. The observation group included 7 660 eyes(4 121 males and 3 539 females), with a mean age of 58.70±14.39 y. The control group included 6 132 eyes(3 358 males and 2 774 females), with a mean age of 58.11±14.74 y. The duration of drug retention was significantly longer in the observation group than in the control group(P<0.001). After classification by disease, patients with diabetic macular edema(DME), wet age-related macular degeneration(wARMD), and retinal vein occlusion-associated macular edema(RVO-ME)in the observation group had significantly higher average numbers of injections, longer system retention times, and higher frequencies of physician changes compared to the control group(all P<0.05). Furthermore, the proportion of patients in the observation group with all three conditions who completed the 3-injection loading phase was higher than that in the control group(all P<0.05).

    CONCLUSION: The establishment of the intravitreal injection center has expanded the scope of services, prolonged patient retention in the care program, and improved the completion rate of the standard 3-injection loading phase of anti-VEGF therapy.

    Reference
    Related
    Cited by
Get Citation

Chen Ruixiang, Jia Wei, Zhang Lei, et al. A comparative study of real-world data before and after the establishment of one-stop intravitreal injection center in Northwest China. Guoji Yanke Zazhi( Int Eye Sci) 2026;26(12):2215-2219

Copy
Article Metrics
  • Abstract:
  • PDF:
Publication History
  • Received:June 25,2026
  • Revised:October 20,2026
  • Adopted:
  • Online: November 09,2026
  • Published: